Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Adcomm Open Public Hearings Have Become Too Sponsor-Driven – US FDA's Pazdur
Apr 09 2024
•
By
Sue Sutter
FDA's Richard Pazdur bemoaned the loss of the organic nature of advisory committee open public hearings. • Source: Shutterstock
More from US FDA Performance Tracker
More from Regulatory Trackers